| Anthrax |
- Schedule: 0,4w,6,12,18m + annual booster
- Route: Intramuscular
- Dose: 0.5ml
|
Required for travel of 15 days or longer to Korea, to include forward deployed Naval forces. Required for III MEF. All others per DoD policy. |
| Cholera |
- Schedule: 1 dose
- Route: Oral
- Dose: 100mL oral suspension
|
Not routinely recommended but may be indicated for deployment to high risk situations. Consult with local Prev Med/Public Health for additional guidance.
|
| COVID-19
|
- Schedule: Pfizer: (2 doses in primary series), Moderna: (2 doses in primary series), Janssen: 1 dose. Booster doses are recommended and should be IAW CDC guidelines.
- Route: Intramuscular
- Dose: Primary Series: Pfizer 0.3mL, Moderna 0.5mL, Janssen 0.5mL
|
Required to be "fully vaccinated" and recommended "up-to-date" IAW CDC guidelines.
|
| Hepatitis A |
- Schedule: 0, 6m (2 dose) or + serologic testing
- Route: Intramuscular
- Dose: 1-18 years, 0.5ml; >=19 years, 1 ml; Twinrix >=18 years, 1ml
|
Required. |
| Hepatitis B |
- Schedule: Engerix-B, Recombivax, Twinrix: 0,1,6m (3 dose)or Heplisav-B: 0,1m (2 dose) or + serologic testing
- Route: Intramuscular
- Dose: Engerix-B or Recombivax: 0-19 years, 0.5ml; >=20 years, 1 ml; Twinrix >=18 years, 1ml; Heplisav-B >=18 years, 0.5mL
|
Required.
|
| Influenza, Northern Hemisphere (NH) |
- Schedule: 1 dose annually
- Route: Intramuscular, Intranasal
- Dose: IM 0.5ml; Intranasal 0.2ml
|
Required if you are residing in / traveling to a designated NH vaccine country by the WHO for 14 or more days from October through March.
|
Influenza, Southern Hemisphere (SH)
|
- Schedule: 1 dose annually
- Route: Intramuscular
- Dose: IM 0.5ml
|
Required if you are residing in / traveling to a designated SH vaccine country by the WHO (including Diego Garcia) for 14 or more days from April through September.
|
| Japanese encephalitis |
- Schedule: 0,28 d (2 dose). One-time booster dose if >11 months after series complete and still in endemic area.
- Route: Intramuscular
- Dose: 0.5ml
|
Required for the following countries and groups: Korea, SOF and III MEF. Required in Japan for PACFLT and USAF in addition to those previously listed. Recommended for all others.
|
| M-M-R |
- Schedule: 2 lifetime doses or + serologic testing
- Route: Subcutaneous
- Dose: 0.5ml
|
Required.
|
| Meningococcal |
- Schedule: If at prolonged risk of disease exposure, vaccinate every 5 yrs.
- Route: Intramuscular
- Dose: 0.5mL
|
Specific countries only - See NCMI recommendations.
|
| Pneumococcal |
- Schedule: High risk 19-64 y/o, 1 dose PCV15 + PPSV23, or 1 dose PCV20. >65y/o, 1 dose PCV15 + PPSV23, or 1 dose PCV20. (All series should be IAW CDC Guidelines)
- Route: PPSV23: SC or IM; PCV15 & PCV20: IM
- Dose: 0.5ml
|
Required for high risk health conditions per ACIP.
|
| Polio |
- Schedule: 1 dose as adult
- Route: Subcutaneous or Intramuscular
- Dose: 0.5ml
|
Required. In the setting of a polio outbreak, comply with CDC or WHO recommendations and if in-country deployment is > 4 weeks, vaccination is required prior to arriving in country.
|
| Rabies |
- Schedule: Pre-Exposure: 0,7,(21 or 28d) Booster: 2-5 yr (when titer drops >1:5)
- Route: Intramuscular
- Dose: 1ml
|
Required for personnel at high risk for exposure IAW Service-Specific guidelines
|
| Tdap or Td |
- Schedule: 1 lifetime dose of Tdap, Td boosters every 10 yrs. For adults who previously have not received a dose of Tdap, 1 dose should be given regardless of interval since last tetanus vaccine.
- Route: Intramuscular
- Dose: 0.5ml
|
Required.
|
| Tick-Borne Encephalitis |
- Schedule: 0, 14d-3m, 5-12m (3 dose) + one-time booster dose 3 years after primary series, if continued exposure expected.
- Route: Intramuscular
- Dose: 0.5mL
|
May be indicated when traveling to forested areas where the disease is endemic, and considered if personal protective measures to prevent insect bites are difficult or suspect.
|
| Typhoid |
- Schedule: Injectable: every 2 yr; Oral: every 5 yr
- Route: Intramuscular or Oral
- Dose: IM 0.5ml; Oral, 4 capsules (day 1,3,5,7)
|
Required for Korea, III MEF and Operational Forces. All others per DoD policy.
|
Varicella (chickenpox)
|
- Schedule: 0, 4-8w (2 dose) or + serologic testing
- Route: Subcutaneous
- Dose: 0.5ml
|
Required. |
Yellow Fever
|
- Schedule: 1 lifetime dose. Must be administered 10 days prior to travel.
- Route: Subcutaneous
- Dose: 0.5ml
|
Required only for entry into some USINDOPACOM countries (per CDC Yellow Book) if traveling from, or transiting through, endemic areas (Africa & South America). CDC 731 Stamp required.
|